In summary, we elucidated for the first time that S6K1 has antiepileptic and antidepressive effects in epilepsy and successfully restores low‐frequency power in epileptic rats, providing more evidence for its potential role in the central nervous system. Here, RPS6KB1 is linked to epilepsy.